Breast cancer is not classically part of the Lynch syndrome tumor spectrum [6], and studies on MMR gene deficiencies in breast cancer remain limited, with most focusing on germline variants [7,8,9,10,11,12,13]. This evidence concerns the gene MRC1 and breast carcinoma.